Overview
Description: “MGF 5mg research protocol outlining study-based dosing for tissue repair and cell activation via subcutaneous injections, with practical insulin-syringe guidance.”
What is MGF?
Mechano Growth Factor (MGF) represents the human IGF-1Ec splice variant that emerges in response to mechanical loading and tissue injury. This peptide has been explored predominantly through in vitro and animal model research for its roles in tissue repair and cellular activation.
The compound arises from alternative splicing of the IGF-1 gene and exhibits distinct expression patterns and E-domain biology when tissues experience loading stress or injury.
Key Reconstitution Information
Standard Dilution Approach:
– Add 3.0 mL bacteriostatic water to the 5mg vial
– Target concentration: approximately 1.67 mg/mL
– This dilution enables clear measurement using U-100 insulin syringes
– At this concentration, 1 unit equals approximately 0.01 mL or 16.7 micrograms
Dosing Framework (Illustrative)
The following table presents a titration schedule for unit conversion practice:
| Week Duration | Daily Dose | Insulin Units | Volume (mL) |
|---|---|---|---|
| Weeks 1–2 | 200 mcg | 12 units | 0.12 mL |
| Weeks 3–4 | 300 mcg | 18 units | 0.18 mL |
| Weeks 5–6 | 400 mcg | 24 units | 0.24 mL |
| Weeks 7–12 | 500 mcg | 30 units | 0.30 mL |
Administration Route: Subcutaneous injection
Frequency: Once daily (measurement framework)
Duration Examples: 8, 12, or 16-week protocols
Critical Context
“Human, evidence‑based dosing for subcutaneous MGF is not established; most literature involves local intramuscular, intracardiac, or systemic administration of MGF isoforms/E‑domain peptides in preclinical models.”
The provided schedule represents a conversion aid for a reconstituted 5mg vial and is not a clinical recommendation.
Storage Instructions
Reconstituted Solution:
– Refrigerate at 2–8 °C (35.6–46.4 °F)
– Label vial with date and concentration
– Protect from light
– Avoid repeated freeze-thaw cycles
– Allow vials to reach room temperature before opening to reduce condensation
Supplies Required
For an 8-week protocol:
– 4 vials of MGF (5mg each)
– 56 U-100 insulin syringes
– 2 bottles of bacteriostatic water (10mL each)
– 112 alcohol swabs
For a 12-week protocol:
– 7 vials of MGF (5mg each)
– 84 U-100 insulin syringes
– 3 bottles of bacteriostatic water (10mL each)
– 168 alcohol swabs
Reconstitution Steps
1. Draw 3.0 mL bacteriostatic water using a sterile syringe
2. Inject slowly down the vial wall to avoid foaming
3. Gently swirl or roll vial to dissolve the peptide
4. Label the vial with the date and concentration (~1.67 mg/mL)
5. Refrigerate immediately at proper temperature
Injection Technique
General Subcutaneous Administration Guidance:
– Clean both the vial stopper and injection site with alcohol; allow to air dry completely
– Pinch a skinfold at the injection site
– Insert the needle at approximately 45-degree angle into subcutaneous tissue
– Do not aspirate before injecting subcutaneously
– Inject slowly and steadily
– Withdraw needle and apply gentle pressure if needed
Site Rotation:
Rotate injection sites among the abdomen, thighs, and upper arms to minimize local irritation and reactions.
Important Safety Considerations
– Use new sterile insulin syringes for each injection
– Dispose of used sharps immediately in a puncture-resistant container
– Do not reuse needles or syringes
– Rotate injection sites to reduce local reactions
– Never share injection equipment
Preclinical Research Context
Cell and animal studies suggest that E-domain peptides may support progenitor cell activation and tissue protection in muscle and neural models. Full-length MGF can engage the insulin-like growth factor-1 receptor in vitro; however, translation to standardized human dosing protocols remains undefined.
Preclinical research has associated local expression and peptide analogs with muscle progenitor activation and tissue protection in animal and cell-based systems.
Potential Benefits & Side Effects
Research-Based Signals (Not Clinical Claims):
– In preclinical systems, MGF has been associated with muscle progenitor activation and cytoprotection
– Local expression following mechanical stress may support adaptive responses
– Common subcutaneous-route experiences with medications include occasional mild injection-site reactions
Injection Site Management:
Rotating injection locations helps minimize localized reactions or discomfort.
Lifestyle Considerations
– Maintain adequate protein intake aligned with research goals
– Combine resistance and aerobic physical activity
– Prioritize sleep and stress management
– Maintain consistency with the injection schedule
Measurement Notes
At the 3.0 mL dilution, per-injection volumes should be at least 10 units for the example doses. For administrations of 10 units or less, consider using 30-unit or 50-unit insulin syringes for improved readability and accuracy.
Important Disclaimer
“This guide is for therapeutic educational purposes only and does not constitute medical advice, diagnosis, or treatment. For research use only.”
This content is intended as an educational resource for understanding peptide measurement and administration techniques. It should not replace professional medical guidance or be used for self-treatment.